MiR-132-3p promotes neuroinflammation and dopaminergic neurodegeneration by suppressing glutaredoxin expression.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of neurochemistry"
DOI: 10.1111/jnc.15477
Abstract: This study aimed to investigate the effect of miR-132-3p/GLRX on neuroinflammation and dopaminergic neurodegeneration in Parkinson's disease (PD). In clinical experiments, the levels of miR-132-3p and glutaredoxin (GLRX) in the midbrain tissuesfrom 5 patients with… read more here.
Keywords: neuroinflammation dopaminergic; mir 132; dopaminergic neurodegeneration; expression ... See more keywords